EBSCO Logo
Connecting you to content on EBSCOhost
Title

Randomized phase II trial of olaparib pembrolizumab vs olaparib alone as maintenance therapy in patients with metastatic pancreatic cancer with germline BRCA1 or BRCA2 mutations: SWOG S2001 NCT04548752.

Authors

Chung, Vincent; Guthrie, Katherine A.; Pishvaian, Michael J.; Lowy, Andrew M.; Sohal, Davendra; Reiss, Kim Anna; Sanford, Nina Niu; Allegra, Carmen; Colby, Sarah; O'Reilly, Eileen M.; Chiorean, E. Gabriela; Philip, Philip Agop

Publication

Journal of Clinical Oncology, 2025, Vol 43, pTPS793

ISSN

0732-183X

Publication type

Academic Journal

DOI

10.1200/JCO.2025.43.4_suppl.TPS793

EBSCO Connect | Privacy policy | Terms of use | Copyright | Manage my cookies
Journals | Subjects | Sitemap
© 2025 EBSCO Industries, Inc. All rights reserved